CW, Loyd JE (2007) Telomerase mutations in families with idiopathic pulmonary ﬁbrosis. N Engl J Med 356: 1317–1326 Artandi SE, Chang S, Lee SL, Alson S, Gottlieb GJ, Chin L, DePinho RA (2000) Telomere dysfunction promotes non-reciprocal trans- locations and epithelial cancers in mice. Nature 406: 641–645 Aubert G, Lansdorp PM (2008) Telomeres and aging. Physiol Rev 88: 557–579 Aviv H, Khan MY, Skurnick J, Okuda K, Kimura M, Gardner J, Priolo L, Aviv A (2001) Age dependent aneuploidy and telomere length of the human vascular endothelium. Atherosclerosis 159: 281–287 Aylon Y, Liefshitz B, Kupiec M (2004) The CDK regulates repair of double-strand breaks by homologous recombination during the cell cycle. EMBO J 23: 4868–4875 Baerlocher GM, Rice K, Vulto I, Lansdorp PM (2007) Longitudinal data on telomere length in leukocytes from newborn baboons support a marked drop in stem cell turnover around 1 year of age. Aging Cell 6: 121–123 Banuelos CA, Banath JP, MacPhail SH, Zhao J, Eaves CA, O’Connor MD, Lansdorp PM, Olive PL (2008) Mouse but not human embryonic stem cells are deﬁcient in rejoining of ionizing radia- tion-induced DNA double-strand breaks. DNA Repair (Amst) 7: 1471–1483 Barker N, van Es JH, Kuipers J, Kujala P, van den Born M, Cozijnsen M, Haegebarth A, Korving J, Begthel H, Peters PJ, Clevers H (2007) Identiﬁcation of stem cells in small intestine and colon by marker gene Lgr5. Nature 449: 1003–1007 Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW (1997) Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 91: 25–34 Bowie MB, Kent DG, Dykstra B, McKnight KD, McCaffrey L, Hoodless PA, Eaves CJ (2007) Identiﬁcation of a new intrinsically timed developmental checkpoint that reprograms key hematopoietic stem cell properties. Proc Natl Acad Sci USA 104: 5878–5882 Bowie MB, McKnight KD, Kent DG, McCaffrey L, Hoodless PA, Eaves CJ (2006) Hematopoietic stem cells proliferate until after birth and show a reversible phase-speciﬁc engraftment defect. J Clin Invest 116: 2808–2816 Britt-Compton B, Rowson J, Locke M, Mackenzie I, Kipling D, Baird DM (2006) Structural stability and chromosome-speciﬁc telomere length is governed by cis-acting determinants in humans. Hum Mol Genet 15: 725–733 Calabrese EJ, Baldwin LA (2003) Toxicology rethinks its central belief. Nature 421: 691–692 Calado RT, Regal JA, Hills M, Yewdell WT, Dalmazzo LF, Zago MA, Lansdorp PM, Hogge D, Chanock SJ, Estey EH, Falcao RP, Young NS (2009) Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia. Proc Natl Acad Sci USA 106: 1187–1192 Calado RT, Young NS (2008) Telomere maintenance and human bone marrow failure. Blood 111: 4446–4455 Cao Y, Bryan TM, Reddel RR (2008) Increased copy number of the TERT and TERC telomerase subunit genes in cancer cells. Cancer Sci 99: 1092–1099 Chang E, Harley CB (1995) Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci USA 92: 11190–11194 Chang S, Multani AS, Cabrera NG, Naylor ML, Laud P, Lombard D, Pathak S, Guarente L, DePinho RA (2004) Essential role of limit- ing telomeres in the pathogenesis of Werner syndrome. Nat Genet 36: 877–882 Cheung I, Schertzer M, Rose A, Lansdorp PM (2006) High incidence of rapid telomere loss in telomerase-deﬁcient Caenorhabditis elegans. Nucleic Acids Res 34: 96–103 Cohen SB, Graham ME, Lovrecz GO, Bache N, Robinson PJ, Reddel RR (2007) Protein composition of catalytically active human telomerase from immortal cells. Science 315: 1850–1853 Cook PJ, Ju BG, Telese F, Wang X, Glass CK, Rosenfeld MG (2009) Tyrosine dephosphorylation of H2AX modulates apoptosis and survival decisions. Nature 458: 591–596 d’Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, Von Zglinicki T, Saretzki G, Carter NP, Jackson SP (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426: 194–198 de Lange T (1995) Telomere dynamics and genome instability in human cancer. In Telomeres, Blackburn EH, Greider CW (eds), pp 265–293. Plainview, NY: Cold Spring Harbor Laboratory Press & 2009 European Molecular Biology Organization Telomeres and disease PM Lansdorp Deng Y, Chan SS, Chang S (2008) Telomere dysfunction and tumour suppression: the senescence connection. Nat Rev Cancer 8: 450–458 Dobzhansky T (1973) Am Biol Teach 35: 125–129 Drost JB, Lee WR (1995) Biological basis of germline mutation: comparisons of spontaneous germline mutation rates among drosophila, mouse, and human. Environ Mol Mutagen 25 (Suppl 26): 48–64 Epel ES, Blackburn EH, Lin J, Dhabhar FS, Adler NE, Morrow JD, Cawthon RM (2004) Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci USA 101: 17312–17315 Essers MA, Offner S, Blanco-Bose WE, Waibler Z, Kalinke U, Duchosal MA, Trumpp A (2009) IFNalpha activates dormant haematopoietic stem cells in vivo. Nature 458: 904–908 Farhat N, Thorin-Trescases N, Voghel G, Villeneuve L, Mamarbachi M, Perrault LP, Carrier M, Thorin E (2008) Stress-induced senes- cence predominates in endothelial cells isolated from athero- sclerotic chronic smokers. Can J Physiol Pharmacol 86: 761–769 Fitzgerald MS, Riha K, Gao F, Ren S, McKnight TD, Shippen DE (1999) Disruption of the telomerase catalytic subunit gene from Arabidopsis inactivates telomerase and leads to a slow loss of telomeric DNA. Proc Natl Acad Sci USA 96: 14813–14818 Fogarty PF, Yamaguchi H, Wiestner A, Baerlocher GM, Sloand E, Zeng WS, Read EJ, Lansdorp PM, Young NS (2003) Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet 362: 1628–1630 Haering CH, Nakamura TM, Baumann P, Cech TR (2000) Analysis of telomerase catalytic subunit mutants in vivo and in vitro in Schizosaccharomycespombe. Proc Natl Acad Sci USA 97: 6367–6372 Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA (1999) Creation of human tumour cells with deﬁned genetic elements. Nature 400: 464–468 Hao LY, Armanios M, Strong MA, Karim B, Feldser DM, Huso D, Greider CW (2005) Short telomeres, even in the presence of telomerase, limit tissue renewal capacity. Cell 123: 1121–1131 Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ, Poustka A, Dokal I (1998) X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 19: 32–38 Hills M, Lucke K, Chavez EA, Eaves CJ, Lansdorp PM (2009) Probing the mitotic history and developmental stage of hemato- poietic cells using single telomere length analysis (STELA). Blood 113: 5765–5775 Kaiser J (2003) Hormesis. A healthful dab of radiation? Science 302: 378 Kang JU, Koo SH, Kwon KC, Park JW, Kim JM (2008) Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. Cancer Genet Cytogenet 182: 1–11 Kim I, Saunders TL, Morrison SJ (2007) Sox17 dependence distin- guishes the transcriptional regulation of fetal from adult hema- topoietic stem cells. Cell 130: 470–483 Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW (1994) Speciﬁc association of human telomerase activity with immortal cells and cancer. Science 266: 2011–2015 Kirkwood TB, Holliday R (1979) The evolution of ageing and longevity. Proc R Soc Lond B Biol Sci 205: 531–546 Kirwan M, Dokal I (2008) Dyskeratosis congenita: a genetic disorder of many faces. Clin Genet 73: 103–112 Lansdorp PM (1997) Self-renewal of stem cells. Biol Blood Marrow Transplant 3: 171–178 Lansdorp PM (2005) Major cutbacks at chromosome ends. Trends Biochem Sci 30: 388–395 Lansdorp PM (2008) Telomeres, stem cells and hematology. Blood 111: 1759–1766 Lansdorp PM, Dragowska W (1993) Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruit- ment of quiescent progenitors. Exp Hematol 21: 1321–1327 Lansdorp PM, Dragowska W, Mayani H (1993) Ontogeny-related changes in proliferative potential of human hematopoietic cells. J Exp Med 178: 787–791 Liu Y, Snow BE, Hande MP, Yeung D, Erdmann NJ, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO, Harrington L (2000) The telomerase reverse transcriptase is limiting and necessary for telomerase function in vivo. Curr Biol 10: 1459–1462 Loeb LA (2001) A mutator phenotype in cancer. Cancer Res 61: 3230–3239 The EMBO Journal VOL 28 | NO 17 | 2009 2539